Abiomed announces q3 earnings per share $1.51

Abiomed announces q3 fy 2020 revenue of $222 million and 31.7% operating margin.q3 gaap earnings per share $1.51.q3 revenue $222 million versus refinitiv ibes estimate of $227 million.q3 earnings per share estimate $1.09 -- refinitiv ibes data.company revised its 2020 revenue guidance to be in the range of $846 million to $877 million, an increase of 10% to 14%.

ABMD Ratings Summary

ABMD Quant Ranking